BlueStar® Genomic Health Care Index
The BlueStar® Genomic Health Care Index (BDNA) tracks the performance of the largest and most liquid companies in the global genomic healthcare industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from health care therapies based on targeting or the modification of the genetic makeup of cells or uses mRNA, technology platforms that enable the development of genetics-based health care thearpies, or laboratory equipment or services used to test, code, or develop genetics-based health care companies.
Index Performance
Index performance of price, total return net and total return gross indexes is displayed in real-time.
Period | Price | Total Return Net |
Year-to-Date Performance | -32.85% | -32.84% |
1-Year Performance | -48.30% | -48.30% |
3-Year Performance | -3.50% | -3.44% |
5-Year Performance | 59.33% | 59.59% |
Since Inception (31 Dec 2015) | 58.30% | 58.69% |
Index Records
Index highs and lows of price, total return net and total return gross indices are displayed in realtime.
Period | Price | Total Return Net |
All Time High/Low | 380.65 / 69.17 | 381.50 / 69.17 |
52-Weeks High/Low | 318.25 / 109.29 | 319.00 / 109.56 |
Quarter High/Low | 158.30 / 128.02 | 158.69 / 128.34 |
Month High/Low | 158.30 / 135.95 | 158.69 / 136.29 |
Index Correlation and Volatility
Index correlation to selected index peers and index volatility are updated daily.
Index Volatility | |
1-month Volatility | 45.22 |
1-year Volatility | 44.31 |
Component Performance
Displayed are the best and worst index components over a selected period of time. Data is updated daily.
Best 5 Components | 1-Year | Year-to-Date | 1-Day |
ILLUMINA INC | -55.16% | -41.39% | -0.35% |
Myriad Genetics Inc | -21.28% | -1.74% | -1.24% |
REGENERON PHARMACEUTICALS | 3.24% | -0.14% | 2.77% |
VERTEX PHARMACEUTICALS INC | 46.48% | 33.86% | 2.06% |
ALNYLAM PHARMACEUTICALS INC | 18.19% | 36.07% | 5.56% |
IONIS PHARMACEUTICALS INC | 17.81% | 50.21% | 0.02% |
QIAGEN NV | -5.56% | -11.03% | -0.50% |
EXACT SCIENCES CORP | -54.11% | -39.86% | -0.51% |
SAREPTA THERAPEUTICS INC | 39.69% | 23.79% | 5.14% |
GUARDANT HEALTH INC | -52.22% | -45.51% | 2.99% |
MODERNA INC | -55.78% | -27.97% | -2.09% |
PRECIGEN INC | -63.13% | -44.74% | -0.97% |
AZENTA INC | -18.86% | -33.07% | -1.44% |
BIONTECH SE | -56.05% | -33.69% | -7.54% |
10X GENOMICS INC | -74.56% | -70.80% | 2.04% |
ARCTURUS THERAPEUTICS HOLDINGS INC | -57.36% | -43.20% | -5.02% |
ARROWHEAD PHARMACEUTICALS INC | -27.43% | -29.08% | 2.31% |
BEAM THERAPEUTICS INC | -41.24% | -20.08% | 0.41% |
BLUEPRINT MEDICINES CORP | -25.55% | -33.63% | 4.33% |
CAREDX INC | -68.03% | -42.68% | -1.21% |
Codexis Inc | -67.34% | -73.55% | -5.49% |
CRISPR THERAPEUTICS AG | -40.48% | 7.40% | -0.01% |
Editas Medicine, Inc. | -65.59% | -27.95% | -1.49% |
Inovio Pharmaceuticals Inc | -74.09% | -52.71% | -0.42% |
INTELLIA THERAPEUTICS INC | -62.05% | -46.30% | 0.27% |
INVITAE CORP | -91.50% | -83.50% | 9.57% |
Krystal Biotech, Inc. | 37.56% | 17.80% | 0.38% |
MeiraGTx Holding plc | -34.60% | -58.76% | -5.41% |
NanoString Technologies Inc | -76.27% | -65.81% | -6.23% |
NATERA INC | -55.53% | -44.15% | 1.34% |
NEOGENOMICS INC | -78.12% | -70.02% | 0.20% |
Oxford BioMedica Plc | -67.58% | -63.74% | -0.21% |
PACIFIC BIOSCIENCES OF CALIFORNIA INC | -78.64% | -66.28% | 13.86% |
Pharming Group NV | -7.66% | 12.57% | 8.68% |
PTC Therapeutics Inc | 33.79% | 34.09% | -0.17% |
REGENXBIO Inc. | 11.15% | 6.42% | -0.68% |
Rocket Pharmaceuticals, Inc | -54.40% | -27.44% | 1.80% |
Sangamo Therapeutics, Inc | -45.80% | -29.47% | 1.73% |
TWIST BIOSCIENCE CORP | -48.94% | -26.92% | 7.18% |
UNIQURE N.V. | -38.93% | -10.13% | -27.02% |
Veracyte Inc | -42.88% | -34.88% | -3.84% |
ADAPTIVE BIOTECHNOLOGIES CORP | -66.89% | -58.34% | 2.10% |
ALLOGENE THERAPEUTICS INC | -31.79% | 6.97% | 3.23% |
ANGES INC | -55.54% | -19.87% | -0.64% |
Fulgent Genetics, Inc. | -50.15% | -47.59% | -11.93% |
GENSCRIPT BIOTECH CORP | -25.60% | -18.10% | -7.18% |
SORRENTO THERAPEUTICS INC | -66.98% | -40.43% | 0.36% |
ABCAM PLC | -26.72% | -36.52% | -0.27% |
AMICUS THERAPEUTICS INC | 19.43% | 8.57% | 2.96% |
Anavex Life Sciences Corporation | -40.74% | -33.97% | -1.80% |
Avidity Biosciences Inc. | -2.69% | -17.80% | 2.90% |
BioNano Genomics, Inc | -59.65% | -14.72% | 5.81% |
Castle Biosciences Inc. | -60.35% | -33.57% | -6.81% |
CUREVAC BV | -76.66% | -59.43% | 1.16% |
DermTech, Inc. | -78.08% | -46.65% | -0.24% |
Design Therapeutics, Inc | 40.00% | 0.05% | -2.33% |
GALAPAGOS NV SPONSORED ADR | -10.04% | -1.87% | -1.10% |
MARAVAI LIFESCIENCES HOLDINGS INC | -51.36% | -37.57% | -2.68% |
Ocugen, Inc. | -63.74% | -37.36% | -0.35% |
Pacific Edge Ltd | -62.43% | -64.72% | -1.15% |
Praxis Precision Medicines, Inc. | -73.37% | -80.05% | 19.82% |
Takara Bio | -41.31% | -31.66% | 0.12% |
23andMe Holding Co. Class A | -54.25% | -40.24% | 9.34% |
4D Molecular Therapeutics, Inc. | -58.46% | -48.72% | -2.00% |
Absci Corp | -85.59% | -52.80% | 4.31% |
Caribou Biosciences, Inc. | -62.26% | -44.00% | -1.17% |
Carsgen Therapeutics Holdings Ltd- B | -41.24% | -42.94% | 0.00% |
DICE Therapeutics, Inc. | 0.00% | -22.01% | 4.22% |
Exscientia Plc ADR | 0.00% | -41.40% | -4.30% |
GINKGO BIOWORKS HOLDINGS INC | -67.63% | -61.01% | 5.54% |
Lyell Immunopharma, Inc. | -51.09% | -1.16% | 5.23% |
OXFORD NANOPORE TECHNOLOGIES PLC | 0.00% | -59.94% | 1.80% |
Sana Biotechnology, Inc. | -56.09% | -44.77% | 3.89% |
Sema4 Holdings Corp. Class A | -82.48% | -54.48% | 2.01% |
Tango Therapeutics, Inc. | -57.38% | -60.69% | 0.47% |
Verve Therapeutics, Inc. | -60.09% | -26.31% | 1.87% |
GreenLight Biosciences Holdings | -62.06% | -62.90% | 1.38% |
Maxcyte Inc | -64.84% | -45.24% | 0.00% |
Sirnaomics Ltd | 0.00% | -33.46% | -0.49% |
Worst 5 Components | 1-Year | Year-to-Date | 1-Day |
ILLUMINA INC | -55.16% | -41.39% | -0.35% |
Myriad Genetics Inc | -21.28% | -1.74% | -1.24% |
REGENERON PHARMACEUTICALS | 3.24% | -0.14% | 2.77% |
VERTEX PHARMACEUTICALS INC | 46.48% | 33.86% | 2.06% |
ALNYLAM PHARMACEUTICALS INC | 18.19% | 36.07% | 5.56% |
IONIS PHARMACEUTICALS INC | 17.81% | 50.21% | 0.02% |
QIAGEN NV | -5.56% | -11.03% | -0.50% |
EXACT SCIENCES CORP | -54.11% | -39.86% | -0.51% |
SAREPTA THERAPEUTICS INC | 39.69% | 23.79% | 5.14% |
GUARDANT HEALTH INC | -52.22% | -45.51% | 2.99% |
MODERNA INC | -55.78% | -27.97% | -2.09% |
PRECIGEN INC | -63.13% | -44.74% | -0.97% |
AZENTA INC | -18.86% | -33.07% | -1.44% |
BIONTECH SE | -56.05% | -33.69% | -7.54% |
10X GENOMICS INC | -74.56% | -70.80% | 2.04% |
ARCTURUS THERAPEUTICS HOLDINGS INC | -57.36% | -43.20% | -5.02% |
ARROWHEAD PHARMACEUTICALS INC | -27.43% | -29.08% | 2.31% |
BEAM THERAPEUTICS INC | -41.24% | -20.08% | 0.41% |
BLUEPRINT MEDICINES CORP | -25.55% | -33.63% | 4.33% |
CAREDX INC | -68.03% | -42.68% | -1.21% |
Codexis Inc | -67.34% | -73.55% | -5.49% |
CRISPR THERAPEUTICS AG | -40.48% | 7.40% | -0.01% |
Editas Medicine, Inc. | -65.59% | -27.95% | -1.49% |
Inovio Pharmaceuticals Inc | -74.09% | -52.71% | -0.42% |
INTELLIA THERAPEUTICS INC | -62.05% | -46.30% | 0.27% |
INVITAE CORP | -91.50% | -83.50% | 9.57% |
Krystal Biotech, Inc. | 37.56% | 17.80% | 0.38% |
MeiraGTx Holding plc | -34.60% | -58.76% | -5.41% |
NanoString Technologies Inc | -76.27% | -65.81% | -6.23% |
NATERA INC | -55.53% | -44.15% | 1.34% |
NEOGENOMICS INC | -78.12% | -70.02% | 0.20% |
Oxford BioMedica Plc | -67.58% | -63.74% | -0.21% |
PACIFIC BIOSCIENCES OF CALIFORNIA INC | -78.64% | -66.28% | 13.86% |
Pharming Group NV | -7.66% | 12.57% | 8.68% |
PTC Therapeutics Inc | 33.79% | 34.09% | -0.17% |
REGENXBIO Inc. | 11.15% | 6.42% | -0.68% |
Rocket Pharmaceuticals, Inc | -54.40% | -27.44% | 1.80% |
Sangamo Therapeutics, Inc | -45.80% | -29.47% | 1.73% |
TWIST BIOSCIENCE CORP | -48.94% | -26.92% | 7.18% |
UNIQURE N.V. | -38.93% | -10.13% | -27.02% |
Veracyte Inc | -42.88% | -34.88% | -3.84% |
ADAPTIVE BIOTECHNOLOGIES CORP | -66.89% | -58.34% | 2.10% |
ALLOGENE THERAPEUTICS INC | -31.79% | 6.97% | 3.23% |
ANGES INC | -55.54% | -19.87% | -0.64% |
Fulgent Genetics, Inc. | -50.15% | -47.59% | -11.93% |
GENSCRIPT BIOTECH CORP | -25.60% | -18.10% | -7.18% |
SORRENTO THERAPEUTICS INC | -66.98% | -40.43% | 0.36% |
ABCAM PLC | -26.72% | -36.52% | -0.27% |
AMICUS THERAPEUTICS INC | 19.43% | 8.57% | 2.96% |
Anavex Life Sciences Corporation | -40.74% | -33.97% | -1.80% |
Avidity Biosciences Inc. | -2.69% | -17.80% | 2.90% |
BioNano Genomics, Inc | -59.65% | -14.72% | 5.81% |
Castle Biosciences Inc. | -60.35% | -33.57% | -6.81% |
CUREVAC BV | -76.66% | -59.43% | 1.16% |
DermTech, Inc. | -78.08% | -46.65% | -0.24% |
Design Therapeutics, Inc | 40.00% | 0.05% | -2.33% |
GALAPAGOS NV SPONSORED ADR | -10.04% | -1.87% | -1.10% |
MARAVAI LIFESCIENCES HOLDINGS INC | -51.36% | -37.57% | -2.68% |
Ocugen, Inc. | -63.74% | -37.36% | -0.35% |
Pacific Edge Ltd | -62.43% | -64.72% | -1.15% |
Praxis Precision Medicines, Inc. | -73.37% | -80.05% | 19.82% |
Takara Bio | -41.31% | -31.66% | 0.12% |
23andMe Holding Co. Class A | -54.25% | -40.24% | 9.34% |
4D Molecular Therapeutics, Inc. | -58.46% | -48.72% | -2.00% |
Absci Corp | -85.59% | -52.80% | 4.31% |
Caribou Biosciences, Inc. | -62.26% | -44.00% | -1.17% |
Carsgen Therapeutics Holdings Ltd- B | -41.24% | -42.94% | 0.00% |
DICE Therapeutics, Inc. | 0.00% | -22.01% | 4.22% |
Exscientia Plc ADR | 0.00% | -41.40% | -4.30% |
GINKGO BIOWORKS HOLDINGS INC | -67.63% | -61.01% | 5.54% |
Lyell Immunopharma, Inc. | -51.09% | -1.16% | 5.23% |
OXFORD NANOPORE TECHNOLOGIES PLC | 0.00% | -59.94% | 1.80% |
Sana Biotechnology, Inc. | -56.09% | -44.77% | 3.89% |
Sema4 Holdings Corp. Class A | -82.48% | -54.48% | 2.01% |
Tango Therapeutics, Inc. | -57.38% | -60.69% | 0.47% |
Verve Therapeutics, Inc. | -60.09% | -26.31% | 1.87% |
GreenLight Biosciences Holdings | -62.06% | -62.90% | 1.38% |
Maxcyte Inc | -64.84% | -45.24% | 0.00% |
Sirnaomics Ltd | 0.00% | -33.46% | -0.49% |